Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07145515

Enhancing Heart Allograft Function With the OCS Heart System Trial

Led by TransMedics · Updated on 2026-01-12

655

Participants Needed

8

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.

CONDITIONS

Official Title

Enhancing Heart Allograft Function With the OCS Heart System Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Donor hearts deemed clinically acceptable for transplantation after physical examination
  • All DCD donors with functional warm ischemic time ≤ 30 minutes
  • DBD donor hearts with expected cross clamp time ≥ 4 hours or with specified organ quality concerns
  • Eligible DBD donor hearts with expected cross clamp time < 4 hours for randomization to treatment arms
  • Signed informed consent and authorization to use protected health information
  • Heart transplant candidate
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Moderate to severe aortic incompetence in donor hearts
  • DBD donors with organ quality concerns including donor age ≥ 40 years, unknown downtime, insignificant coronary artery disease, or left ventricular ejection fraction ≤ 50%
  • Participants involved in other interventional clinical trials that may affect outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

University of California San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

2

Tampa General Hospital

Tampa, Florida, United States, 33606

Actively Recruiting

3

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

4

Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

5

Columbia University Irving Medical Center/ New York Presbyterian Hospital

New York, New York, United States, 10032

Not Yet Recruiting

6

Westchester Medical Center

Valhalla, New York, United States, 10595

Actively Recruiting

7

Duke University

Durham, North Carolina, United States, 27710

Actively Recruiting

8

Baylor Scott and White

Dallas, Texas, United States, 75226

Actively Recruiting

Loading map...

Research Team

R

Raicca Haqqi

CONTACT

K

Kausar Qidwai

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here